Month: September 2016

  1. Home
  2. 2016
  3. Sep
September 18, 2016

First Decision on Inter Partes Review (IPR) Proceedings in Supreme Court of United States

On June 20, 2016, the Supreme Court of United States issued its first decision addressing IPR proceedings—Cuozzo Speed Technologies v. Lee. The court’s decision upheld the claim construction standard (“broadest reasonable interpretation” BRI rather than the “plain and ordinary meaning” standard applicable in courts) applied in IPR proceedings and confirmed that appeals may only be taken from the board’s final written decisions […]

Read More
September 15, 2016

Lacosamide Patent Valid_District Court Decision

UCB has received a major boost after a Delaware district court confirmed the validity of the company’s patents on one of its major drugs, the anti-seizure drug Vimpat (lacosamide). The case relates to ANDA litigation and involves patent number RE38551 (OB Listed). The court agreed with plaintiffs general characterization of the record: Vimpat® is the result of Dr. Kohn’s decade long […]

Read More
September 7, 2016

Federal court clarifies Test For Patentable Subject Matter_Abstract ideas

The Federal Circuit on Aug 1, 2016, upheld a district court’s summary judgment against Electric in Electric Power Group, LLC v. Alstom S.A., No. 2015-1778 (Fed. Cir. Aug. 1, 2016). This case involves the eligibility for patenting, under 35 U.S.C. § 101, of certain claims of three of Electric Power Group, LLC’s patents, U.S. Patent Nos. 7233843, 8060259, and 8401710. Electric’s claims […]

Read More

Recent Posts